American multinational medical devices and health care company Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) announced on Monday a multi-year 'food is medicine' effort, called the NACHC and Abbott Food for Health Initiative, aimed at making healthy, nutritious food a core part of primary healthcare at Community Health Centers (CHCs) across the US.
The NACHC-Abbott partnership will include a national certification program designed to help CHCs develop the systems and capacity to advance food for health, along with structured learning, training and knowledge-sharing for CHC staff to build capabilities and expertise in addressing immediate nutrition needs, integrating nutrition into healthcare delivery, and preventing and managing nutrition-related chronic diseases.
The framework is made up of three key components: Food for Health Learning Lab, a structured learning program designed to build nutrition literacy and expertise across the CHC workforce, and guide health centres in implementing and measuring food is medicine efforts; Food for Health Community of Practice, a national peer-learning network that will connect health centres to share promising practices, troubleshoot challenges and learn from top experts; Food for Health CORE (Certification of Readiness and Excellence), a voluntary national certification program that will recognize and support CHCs in developing the systems, processes and competencies needed to advance food for health efforts.
The NACHC and Abbott Food for Health Initiative is a signature program of NACHC's Center for Nutrition and Health, bringing together public and private partners, CHCs, and other stakeholders. The centre's broader goal is to serve as an innovation hub dedicated to moving food-based clinical care from separate efforts to a coordinated body of programs and policy initiatives that improve health outcomes.
Aptar and Aceso Therapeutics partner to advance inhaled cystic fibrosis therapy
Immuron signs US distribution deal for PROIBS
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial
Sectra to provide Education Portal to Loyalist College for medical imaging training
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
Abbott and NACHC launch nationwide Food for Health initiative
Galmed reports positive preclinical results for Aramchol in prostate cancer
Galderma receives EU approval for Restylane Shaype facial shaping injectable